Limited coverage drugs – tiotropium

Last updated on May 2, 2024


Generic name

tiotropium (Lupin-Tiotropium LupinHaler® and Spiriva Handihaler® ONLY)


18 mcg dry powder for oral inhalation

Special Authority criteria

Approval period

Diagnosis of chronic obstructive pulmonary disease (COPD)


Failure after a minimum one-month trial of each of the regular benefit long-acting muscarinic receptor antagonist (LAMA) products (see notes)


Practitioner exemptions

  • None

Special notes

  • The Regular Benefit LAMA products are the following:
    • Tiotropium (Spiriva® Respimat®)
    • Umeclidinium (Incruse® Ellipta®)

Special Authority requests